A comprehensive blood-based screening service designed to detect multiple cancer types simultaneously through gene methylation analysis. This service utilizes advanced NGS technology and is available as a clinical testing service.
Manufactured by
China
BioChain (Beijing) Science & Technology Inc. is a pioneer in cancer early diagnosis and screening in China. The company specializes in developing NGS and PCR-based cancer gene methylation detection products, focusing on early cancer diagnosis reagent kits and large-scale laboratory screening platforms.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Yashraj Biotechnology GmbH
Germany · 1 relevant product
PreceDo Pharmaceuticals Co.Ltd.
China · 2 relevant products
Eone-Diagnomics Genome Center
South Korea · 5 relevant products
Life Medical Diagnostics LLC
United Arab Emirates · 1 relevant product
Origin Biotechnology Co., Ltd.
Taiwan · 3 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 13 relevant products
GENETRON HEALTH (BEIJING) CO., LTD
China · 4 relevant products
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 2 relevant products
Diatech Pharmacogenetics srl
Italy · 1 relevant product
NOROVA
China · 1 relevant product
48 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 94 closest product alternatives
Yashraj Biotechnology GmbH · Germany
Comprehensive service for discovering and identifying new cancer biomarkers in human serum and plasma samples to advance precision medicine and diagnostics.
PreceDo Pharmaceuticals Co.Ltd. · China
A high-throughput drug sensitivity testing platform utilizing renewable primary cancer cells to predict treatment response. This service enables personalized treatment selection through comprehensive chemotherapy and targeted drug profiling.
Eone-Diagnomics Genome Center · South Korea
A noninvasive liquid biopsy service based on next-generation sequencing (NGS) technology that analyzes fetal DNA from maternal blood starting from week 10 of pregnancy in singletons and week 12 in twins. The service provides fetal sex identification and comprehensive chromosomal abnormality screening.
Life Medical Diagnostics LLC · United Arab Emirates
Advanced molecular diagnostic testing service for genetic and molecular-level analysis of diseases. The service enables precise diagnosis and personalized treatment approaches.
Origin Biotechnology Co., Ltd. · Taiwan
A diagnostic service for prenatal screening and diagnosis, focusing on molecular detection techniques for maternal and fetal health assessment.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based molecular diagnostic test designed for early detection and risk assessment across multiple cancer types. The test utilizes proprietary methylation technology to identify cancer signals in biological samples.
GENETRON HEALTH (BEIJING) CO., LTD · China
HCCscreen is a cancer early detection technology and service based on circulating free DNA (cfDNA) and blood biomarkers for hepatocellular carcinoma screening. Clinical data from 1,615 asymptomatic individuals demonstrated 88% sensitivity and 93% specificity, outperforming ultrasound screening which showed 71% sensitivity and 95% specificity. The service is available through hospital networks, government screening programs, physical examination centers, and online health platforms.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
High-throughput sequencing detection service for tumor-derived circulating free DNA genetic mutations, enabling precise tumor profiling and monitoring. The service has passed national inter-laboratory quality assessments with full marks.
GENETRON HEALTH (BEIJING) CO., LTD · China
Multi-biomarker screening solution for early-stage cancer identification. Analyzes blood samples to detect cancer-associated molecular signatures. Facilitates timely clinical intervention and improved patient outcomes.
Diatech Pharmacogenetics srl · Italy
Molecular testing service for monitoring deep response in chronic myeloid leukemia patients from diagnosis through treatment follow-up. Utilizes genomic sequencing and variant analysis to track disease progression and treatment effectiveness.
NOROVA · China
Precision diagnostic service utilizing liquid biopsy technology for early detection and monitoring of malignant tumors. Analyzes circulating biomarkers from patient blood samples. Enables non-invasive assessment of tumor characteristics and treatment response.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic test utilizing DNA methylation technology for early detection of lung cancer. Enables risk assessment and early diagnosis of lung malignancies through liquid biopsy methodology.
82 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products